BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12439697)

  • 21. GM-CSF versus G-CSF: engraftment characteristics, resource utilization, and cost following autologous PBSC transplantation.
    Zumberg MS; Leather HL; Nejame C; Meyer C; Wingard JR
    Cytotherapy; 2002; 4(6):531-8. PubMed ID: 12568989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.
    Villela L; Sureda A; Canals C; Sanz MA; Martino R; Valcárcel D; Altés A; Briones J; Gómez M; Brunet S; Sierra J
    Haematologica; 2003 Mar; 88(3):300-5. PubMed ID: 12651269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation.
    Capizzi SA; Kumar S; Huneke NE; Gertz MA; Inwards DJ; Litzow MR; Lacy MQ; Gastineau DA; Prakash UB; Tefferi A
    Bone Marrow Transplant; 2001 Jun; 27(12):1299-303. PubMed ID: 11548849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A noninvasive oral rinse assay to monitor engraftment, neutrophil tissue delivery and susceptibility to infection following HSCT in pediatric patients.
    Cheretakis C; Dror Y; Glogauer M
    Bone Marrow Transplant; 2005 Aug; 36(3):227-32. PubMed ID: 15937506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early identification and management of graft failure after unrelated cord blood transplantation.
    Chan KW; Grimley MS; Taylor C; Wall DA
    Bone Marrow Transplant; 2008 Jul; 42(1):35-41. PubMed ID: 18332909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of immature platelet fraction and immature reticulocyte fraction as predictors of engraftment after hematopoietic stem cell transplantation.
    Morkis IV; Farias MG; Rigoni LD; Scotti L; Gregianin LJ; Daudt LE; Silla LM; Paz AA
    Int J Lab Hematol; 2015 Apr; 37(2):259-64. PubMed ID: 25066534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.
    Cohen N; Mihu CN; Seo SK; Chung D; Chou J; Heller G; Papanicolaou GA
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1337-41. PubMed ID: 19747643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
    Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
    Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective randomized comparative observation of single- versus split-dose lenograstim to enhance engraftment after autologous stem cell transplantation in patients with multiple myeloma or non-Hodgkin's lymphoma.
    Jang G; Ko OB; Kim S; Lee DH; Huh J; Suh C
    Transfusion; 2008 Apr; 48(4):640-6. PubMed ID: 18194384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation - frequency and outcomes.
    Lee KH; Lee JH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Lee JS
    Bone Marrow Transplant; 2004 Apr; 33(7):729-34. PubMed ID: 14755315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful engraftment following allogeneic stem cell transplantation in very high-risk patients with busulfan as a single agent.
    Bitan M; Or R; Shapira MY; Resnick IB; Ackerstein A; Samuel S; Elad S; Slavin S
    Haematologica; 2005 Aug; 90(8):1089-95. PubMed ID: 16079108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytopenia and hematopoietic recovery after low intensity conditioning transplants.
    Kostova G; Heim D; Passweg J; Buser A; Tichelli A; Gratwohl A
    Croat Med J; 2004 Aug; 45(4):445-50. PubMed ID: 15311417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis.
    Oran B; Malek K; Sanchorawala V; Wright DG; Quillen K; Finn KT; La Valley M; Skinner M; Seldin DC
    Bone Marrow Transplant; 2005 Mar; 35(6):567-75. PubMed ID: 15665842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total body irradiation, fludarabine, melphalan, and allogeneic hematopoietic stem cell transplantation for advanced pediatric hematologic malignancies.
    Petropoulos D; Worth LL; Mullen CA; Madden R; Mahajan A; Choroszy M; Ha CS; Champlin RC; Chan KW
    Bone Marrow Transplant; 2006 Mar; 37(5):463-7. PubMed ID: 16435013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posttransplant thrombopoiesis predicts survival in patients undergoing autologous hematopoietic progenitor cell transplantation.
    Ninan MJ; Flowers CR; Roback JD; Arellano ML; Waller EK
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):895-904. PubMed ID: 17640593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
    Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
    Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery from neutropenia can be predicted by the immature reticulocyte fraction several days before neutrophil recovery in autologous stem cell transplant recipients.
    Grazziutti ML; Dong L; Miceli MH; Cottler-Fox M; Krishna SG; Fassas A; van Rhee F; Barlogie BM; Anaissie EJ
    Bone Marrow Transplant; 2006 Feb; 37(4):403-9. PubMed ID: 16400338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.